Good job Sox! Way to put that putz in his place...
Post# of 72446
Posted On: 08/24/2016 1:49:41 PM
Good job Sox! Way to put that putz in his place...
Lutz said, "These big Pharma co's don't even know about CTIX."
The response from Sox...
"I think it's safe to say that at least one BP knows about CTIX."
Approximately one year ago, we disclosed “Cellceutix has signed an agreement with a division of one of the largest U.S. pharmaceutical companies for testing Brilacidin as a component of certain implanted devices as a means to prevent infection. This potential prophylactic use was not part of Cellceutix’s strategic plans for Brilacidin, but given the compilation of clinical and laboratory data, it is a logical application that could potentially add millions of dollars of revenue to the Company. The material transfer does not cover the pharmaceutical use of Brilacidin for treatment of infections or other diseases. A final contract can only be entered into if and when Brilacidin receives Food and Drug Administration (FDA) approval.” We are pleased to report that this pharmaceutical company recently ordered additional Brilacidin for further testing. We interpret this as a positive sign and remain optimistic about this application for Brilacidin.
http://cellceutix.com/cellceutix-completes-la...1kXpN.dpuf
Lutz said, "These big Pharma co's don't even know about CTIX."
The response from Sox...
"I think it's safe to say that at least one BP knows about CTIX."
Approximately one year ago, we disclosed “Cellceutix has signed an agreement with a division of one of the largest U.S. pharmaceutical companies for testing Brilacidin as a component of certain implanted devices as a means to prevent infection. This potential prophylactic use was not part of Cellceutix’s strategic plans for Brilacidin, but given the compilation of clinical and laboratory data, it is a logical application that could potentially add millions of dollars of revenue to the Company. The material transfer does not cover the pharmaceutical use of Brilacidin for treatment of infections or other diseases. A final contract can only be entered into if and when Brilacidin receives Food and Drug Administration (FDA) approval.” We are pleased to report that this pharmaceutical company recently ordered additional Brilacidin for further testing. We interpret this as a positive sign and remain optimistic about this application for Brilacidin.
http://cellceutix.com/cellceutix-completes-la...1kXpN.dpuf
(3)
(0)